Both drugs significantly suppressed clinical symptoms of arthritis, C-reactive protein (CRP) and IL-6 inflammatory biomarkers, and anti-collagen type II serum antibody responses (both IgM and IgG). The gene discussed is CRP; the disease is arthritic joint disease.